Background and objectives: Blockade of the trigeminal nerve and its branches is an effective diagnostic tool and potential treatment of facial pain. Ultrasound-guided injections in the pterygopalatine fossa (PPF) to block the trigeminal nerve divisions and sphenopalatine ganglion have been described but a consensus has yet to be reached over the ideal approach. We sought to delineate and compare the various approaches to the ultrasound-guided trigeminal divisions blockade via the PPF.
Methods: The literature search was performed by searching the National Library of Medicine's PubMed database, the Cochrane Database of Systematic Reviews and Google Scholar within the date range of January 2009-March 2019 for keywords targeted toward "trigeminal nerve," "maxillary nerve," or "pterygopalatine fossa," "ultrasound," and "nerve block," using an English language restriction. Six papers were included in the final review: one prospective double-blinded randomized controlled trial, one prospective descriptive study, one case series, two case reports, and one cadaveric study.
Results: There are three main approaches to the ultrasound-guided trigeminal nerve branches blockade via the PPF: anterior infrazygomatic in-plane, posterior infrazygomatic in-plane, and suprazygomatic out-of-plane approaches. Each showed injectate spread to the PPF in cadaver, adult and pediatric patients, respectively.1-5 Injectate used varied from 3 to 5 mL to 0.15 mL/kg.
Conclusions: These studies demonstrated that the PPF is a readily accessible target for the ultrasound-guided maxillary nerve block via three main approaches.2 The ideal approach is yet to be determined and must be further explored.
Keywords: chronic pain: diagnostic pain procedures; chronic pain: head and neck; chronic pain: imaging; interventional pain management; ultrasound in pain medicine.
© American Society of Regional Anesthesia & Pain Medicine 2020. No commercial re-use. See rights and permissions. Published by BMJ.